New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19.
Renata Moll-BernardesJuliana R FerreiraEduardo B SchaustzAndréa Silvestre de SousaJoão D MattosMariana B TortellyAdriana L PimentelAna Cristina B S FigueiredoMarcia M Noya-RabeloSergio FortierFlavia A Matos E SilvaNarendra VeraLuciana CondeMauro Jorge Cabral-CastroDenilson C AlbuquerquePaulo Henrique Rosado-de-CastroGabriel C CamargoMartha V T PinheiroDaniele O L FreitasAna M PittellaJosé Afonso M AraújoAndré C MarquesElias P GouvêaFlavia V O TerziCleverson N ZukowskiRonaldo A O C GismondiBruno S BandeiraRenée S OliveiraBarbara E J AbufaiadJacqueline S S MirandaLuiz Guilherme MirandaOlga F SouzaFernando A BozzaRonir Raggio LuizEmiliano MedeiPublished in: Journal of clinical immunology (2023)
MFI are immune biomarkers of myocardial injury in hypertensive patients with COVID-19. The immune signature described here may aid in understanding the mechanisms underlying myocardial injury in these patients. The study data might open a new window for improvement in the treatment of hypertensive patients with COVID-19 and myocardial injury.